Valuation: Ecomax, Inc.

Market Cap 419K 376K 350K 317K 598K 40.13M 602K 4.2M 1.65M 20.67M 1.57M 1.54M 66.46M P/E 2022
-14.8x
P/E 2023 -25x
Enterprise Value 835K 748K 697K 632K 1.19M 79.93M 1.2M 8.38M 3.28M 41.17M 3.13M 3.07M 132M EV / Sales 2022
-
EV / Sales 2023 6,589,581x
Free-Float
8.59%
Yield 2022 *
-
Yield 2023 -
1 year 0
Extreme 0.0003
0
3 years 0
Extreme 4.0E-5
0.89
5 years 0
Extreme 4.0E-5
1.95
10 years 0
Extreme 4.0E-5
5.7
Manager TitleAgeSince
Chief Executive Officer 43 2022-09-29
Director TitleAgeSince
Chairman 43 2022-09-29
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-99.95% 714
-0.68%-1.56%+27.19%+60.48% 32.53B
-1.77%+0.27%-42.37%+540.69% 25.48B
-0.51%+4.56%+3.31%+48.27% 24.39B
-0.74%+6.46%-38.33%-14.99% 17.56B
+0.82%+3.28%-8.31% - 16.37B
+0.53%+0.18%-35.07%+30.15% 12.15B
+0.83%+2.19%+37.17% - 11.4B
+2.91%+4.74%-20.45%+166.56% 9.47B
+2.90%+7.03%-50.04%+12.33% 7.62B
Average +0.43%+3.00%-12.69%+92.94% 15.7B
Weighted average by Cap. -0.09%+2.93%-9.56%+144.70%

Financials

2022 2023
Net sales - 0.42 0.38 0.35 0.32 0.61 40.64 0.61 4.26 1.67 20.93 1.59 1.56 67.31
Net income -115K -103K -95.64K -86.77K -164K -10.97M -165K -1.15M -450K -5.65M -430K -421K -18.18M -89.92K -80.6K -75.04K -68.08K -128K -8.61M -129K -902K -353K -4.44M -338K -330K -14.26M
Net Debt 191K 171K 159K 145K 273K 18.3M 275K 1.92M 750K 9.43M 718K 702K 30.31M 416K 373K 347K 315K 594K 39.8M 597K 4.17M 1.63M 20.5M 1.56M 1.53M 65.91M
Logo Ecomax, Inc.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Employees
1
  1. Stock Market
  2. Stocks
  3. EMAX Stock